ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INTERNAT MEDICAL INNOVATIONS I, PHARMAESSENTIA CORP and OPTIMER PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Winqvist Ola | 16 |
#2 | Gregory Matt | 10 |
#3 | Moss Steven | 10 |
#4 | Lindh Emma | 9 |
#5 | Wallin Robert | 9 |
#6 | Lundgren Yen | 1 |
#7 | Lind Emma | 1 |
#8 | Walin Robert | 1 |
Publication | Filing date | Title |
---|---|---|
AU2019237257A1 | Combinations of macrolide compounds and immune checkpoint inhibitors | |
AU2018226340A1 | Novel immune stimulating macrolides | |
AU2018225391A1 | Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics | |
AU2018209238A1 | Novel use of known compounds- intracellular infections | |
AU2018209239A1 | Novel compounds (immunorhelins- intracellular infections) |